Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones

Tuesday, May 17, 2011 General News
Email Print This Page Comment bookmark
Font : A-A+

Cardium Therapeutics, Inc.

Reconciliation of Non-GAAP Measure

As of March 31, 2011

Three Months Ended March 31,

2011

2010

Net Loss

$  (1,688,640)

$  (1,039,816)

    Add (subtract)

Stock-based compensation expense

22,519

120,479

Change in fair value of derivative liabilities

(88,170)

(437,370)

Non-GAAP net loss

$     (1,754,291)

$     (1,356,707)

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store